VAERS reports by lot

Moderna COVID-19 lot 063B22A: VAERS reports

102 VAERS reports list lot 063B22A as a Moderna COVID-19 vaccine, received between 2022-09-09 and 2024-01-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
102
Reports
4%
Marked serious
4
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological926%
Respiratory721%
Injection-site / Local reaction515%
Gastrointestinal412%
Allergic / Anaphylactic26%
Musculoskeletal26%
Dermatological (non-injection-site)26%
General / Systemic (non-local)26%
Cardiac / Cardiovascular13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas23
California9
Ohio6
Florida5
Michigan4
Colorado4
Connecticut3
Indiana3
South Dakota3
Idaho3
North Carolina3
Kentucky2

Reports by month received

2022-0911
2022-1015
2022-1138
2022-1212
2023-014
2023-026
2023-034
2023-048
2023-061
2023-091
2023-121
2024-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.